Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -23.02%1.34B | 2.30%1.75B | -26.94%1.71B | 22.91%2.34B | 19.95%1.9B | -12.19%1.58B | 3.69%1.8B | 4.93%1.74B | 2.80%1.66B | -0.03%1.61B |
| Operating revenue | -23.02%1.34B | 2.30%1.75B | -26.94%1.71B | 22.91%2.34B | 19.95%1.9B | -12.19%1.58B | 3.69%1.8B | 4.93%1.74B | 2.80%1.66B | -0.03%1.61B |
| Cost of revenue | -4.59%214M | 0.27%224.3M | -29.37%223.7M | 17.04%316.7M | 33.10%270.6M | -1.55%203.3M | 4.56%206.5M | 11.96%197.5M | 4.07%176.4M | 5.31%169.5M |
| Gross profit | -25.74%1.13B | 2.61%1.52B | -26.56%1.48B | 23.89%2.02B | 18.01%1.63B | -13.56%1.38B | 3.58%1.6B | 4.09%1.54B | 2.65%1.48B | -0.62%1.44B |
| Operating expense | -22.41%1.13B | 5.15%1.46B | -9.57%1.39B | 10.33%1.53B | 6.14%1.39B | -12.01%1.31B | 0.95%1.49B | 5.22%1.47B | 8.38%1.4B | 3.37%1.29B |
| Selling and administrative expenses | -26.38%685.7M | 7.33%931.4M | -8.79%867.8M | 7.72%951.4M | 8.22%883.2M | -28.26%816.1M | 7.22%1.14B | 6.26%1.06B | 8.79%998.5M | 5.92%917.8M |
| -General and administrative expense | -26.38%685.7M | 7.33%931.4M | -8.79%867.8M | 7.72%951.4M | 8.22%883.2M | -28.26%816.1M | 7.22%1.14B | 6.26%1.06B | 8.79%998.5M | 5.92%917.8M |
| Depreciation amortization depletion | -20.23%224.3M | 1.44%281.2M | -0.47%277.2M | 12.62%278.5M | 13.44%247.3M | 217.32%218M | -40.36%68.7M | -15.67%115.2M | -12.83%136.6M | -3.32%156.7M |
| -Depreciation and amortization | -20.23%224.3M | 1.44%281.2M | -0.47%277.2M | 12.62%278.5M | 13.44%247.3M | 217.32%218M | -40.36%68.7M | -15.67%115.2M | -12.83%136.6M | -3.32%156.7M |
| Other operating expenses | -9.76%220M | 1.54%243.8M | -20.42%240.1M | 17.07%301.7M | -5.88%257.7M | -2.25%273.8M | -5.44%280.1M | 12.07%296.2M | 21.97%264.3M | -1.74%216.7M |
| Operating profit | -99.69%200K | -33.23%65.5M | -79.89%98.1M | 101.69%487.9M | 229.56%241.9M | -34.23%73.4M | 58.52%111.6M | -14.98%70.4M | -45.81%82.8M | -25.08%152.8M |
| Net non-operating interest income (expenses) | 8.05%-65.1M | -13.64%-70.8M | -23.37%-62.3M | 42.35%-50.5M | -195.95%-87.6M | 13.45%-29.6M | 2.56%-34.2M | 18.56%-35.1M | 25.69%-43.1M | 12.80%-58M |
| Non-operating interest expense | -12.33%26.3M | 4.90%30M | 84.52%28.6M | -71.08%15.5M | 53,700.00%53.6M | -100.29%-100K | -2.56%34.2M | -18.56%35.1M | -25.69%43.1M | -12.80%58M |
| Total other finance cost | -4.90%38.8M | 21.07%40.8M | -3.71%33.7M | 2.94%35M | 14.48%34M | --29.7M | ---- | ---- | ---- | ---- |
| Other net income (expenses) | 18.24%-527.2M | -48.88%-644.8M | -2,012.68%-433.1M | -251.85%-20.5M | 419.23%13.5M | -55.17%2.6M | 200.00%5.8M | 98.95%-5.8M | -1,338.80%-552.5M | 63.79%-38.4M |
| Special income (charges) | 17.23%-506M | -51.76%-611.3M | ---402.8M | ---- | ---- | ---10.2M | ---- | 98.95%-5.8M | -737.12%-552.5M | ---66M |
| -Less:Restructuring and mergern&acquisition | 33.33%10.8M | -41.73%8.1M | --13.9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | -17.90%495.2M | 55.10%603.2M | --388.9M | ---- | ---- | --10.2M | ---- | -98.95%5.8M | 737.12%552.5M | --66M |
| Other non-operating income (expenses) | 36.72%-21.2M | -10.56%-33.5M | -47.80%-30.3M | -251.85%-20.5M | 5.47%13.5M | 120.69%12.8M | --5.8M | ---- | ---- | 126.03%27.6M |
| Income before tax | 8.92%-592.1M | -63.63%-650.1M | -195.30%-397.3M | 148.45%416.9M | 261.64%167.8M | -44.23%46.4M | 128.57%83.2M | 107.10%36.4M | -1,009.22%-512.8M | 79.62%56.4M |
| Income tax | -106.38%-29.1M | 18.50%-14.1M | -114.08%-17.3M | 21.08%122.9M | 496.48%101.5M | -193.77%-25.6M | -0.73%27.3M | 570.73%27.5M | -77.47%4.1M | 117.32%18.2M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 76.59%-151.2M | -75.58%-645.8M | -219.45%-367.8M | 604.58%307.9M | 161.99%43.7M | -226.12%-70.5M | 528.09%55.9M | 101.72%8.9M | -791.97%-516.9M | -45.27%74.7M |
| Net income continuous operations | 11.48%-563M | -67.37%-636M | -229.25%-380M | 343.44%294M | -7.92%66.3M | 28.80%72M | 528.09%55.9M | 101.72%8.9M | -1,453.14%-516.9M | -72.01%38.2M |
| Net income discontinuous operations | 4,302.04%411.8M | -180.33%-9.8M | -12.23%12.2M | 161.50%13.9M | 84.14%-22.6M | ---142.5M | ---- | ---- | ---- | --36.5M |
| Noncontrolling interests | 50.00%-100K | -200K | ||||||||
| Net income attributable to the company | 76.59%-151.2M | -75.58%-645.8M | -219.45%-367.8M | 604.58%307.9M | 161.99%43.7M | -226.12%-70.5M | 528.09%55.9M | 101.72%8.9M | -789.99%-516.8M | -45.13%74.9M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 76.59%-151.2M | -75.58%-645.8M | -219.45%-367.8M | 604.58%307.9M | 161.99%43.7M | -226.12%-70.5M | 528.09%55.9M | 101.72%8.9M | -789.99%-516.8M | -45.13%74.9M |
| Diluted earnings per share | 78.73%-0.2082 | -63.83%-0.9788 | -222.32%-0.5975 | 647.45%0.4884 | 162.48%0.0653 | -222.83%-0.1046 | 460.92%0.0852 | 101.72%0.0152 | -788.19%-0.8849 | -46.07%0.1286 |
| Basic earnings per share | 78.73%-0.2082 | -63.83%-0.9788 | -224.09%-0.5975 | 636.83%0.4815 | 162.48%0.0653 | -222.83%-0.1046 | 460.92%0.0852 | 101.72%0.0152 | -788.19%-0.8849 | -46.07%0.1286 |
| Dividend per share | 0 | 0 | -64.18%0.0555 | 157.69%0.155 | 8.33%0.0602 | -35.48%0.0555 | -11.56%0.0861 | -2.68%0.0973 | -32.53%0.1 | -17.00%0.1482 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |